ARYA Sciences Acquisition Corp III Contracts & Agreements
45 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (2)
- Human Resources (22)
- Uncategorized (8)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Matthew Murphy, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Confirmatory Employment Letter between Nautilus Biotechnology, Inc. and Sujal Patel, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Confirmatory Employment Letter between Nautilus Biotechnology, Inc. and Parag Mallick, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Confirmatory Employment Letter between Nautilus Biotechnology, Inc. and Anna Mowry, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Confirmatory Employment Letter between Nautilus Biotechnology, Inc. and Nick Nelson, dated of as July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Confirmatory Employment Letter between Nautilus Biotechnology, Inc. and Gwen Weld, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Confirmatory Employment Letter between Nautilus Biotechnology, Inc. and Mary Godwin, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Confirmatory Employment Letter between Nautilus Biotechnology, Inc. and Subra Sankar, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Confirmatory Employment Letter between Nautilus Biotechnology, Inc. and Matthew Murphy, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Sujal Patel, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Parag Mallick, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Anna Mowry, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Nick Nelson, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Gwen Weld, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Mary Godwin, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Amended and Restated Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Subra Sankar, dated as of July 31, 2023 (Filed With SEC on August 2, 2023)
- Description of Securities (Filed With SEC on February 23, 2023)
- Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and (Filed With SEC on August 2, 2022)
- Offer Letter between Nautilus Biotechnology, Inc. and (Filed With SEC on August 2, 2022)
- Change in Control and Severance Agreement between Nautilus Biotechnology, Inc. and Gwen Weld dated April 12, 2022 (Filed With SEC on May 3, 2022)
- Offer Letter between Nautilus Biotechnology, Inc. and Gwen Weld dated March 28, 2022 (Filed With SEC on May 3, 2022)
- Nautilus Biotechnology, Inc (Filed With SEC on June 10, 2021)
- Nautilus Biotechnology, Inc. 2021 Employee Stock Purchase (Filed With SEC on June 10, 2021)
- Specimen Common Stock Certificate (Filed With SEC on June 10, 2021)
- Description of Registrants Securities (Filed With SEC on March 30, 2021)
- Nautilus Biotechnology, Inc. 2017 Equity Incentive Plan and forms of agreements thereunder (Filed With SEC on March 26, 2021)
- Form of Restricted Stock Award Agreement under the Nautilus Biotechnology, Inc. 2021 Equity Incentive Plan (Filed With SEC on March 26, 2021)
- Form of Restricted Stock Unit Agreement under the Nautilus Biotechnology, Inc. 2021 Equity Incentive Plan (Filed With SEC on March 26, 2021)
- Form of Stock Option Agreement under the Nautilus Biotechnology, Inc. 2021 Equity Incentive Plan (Filed With SEC on March 26, 2021)
- Private Placement Shares Purchase Agreement between the Company and the Sponsor (Filed With SEC on August 12, 2020)
- Underwriting Agreement among the Company, Jefferies LLC and Goldman Sachs & Co. LLC (Filed With SEC on August 12, 2020)
- Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Company (Filed With SEC on August 12, 2020)
- Registration and Shareholder Rights Agreement among the Company, the Sponsor and certain other equityholders named therein (Filed With SEC on August 12, 2020)
- Letter Agreement among the Company, the Sponsor and the Companys officers and directors (Filed With SEC on August 12, 2020)
- Administrative Services Agreement between the Company and the Sponsor (Filed With SEC on August 12, 2020)
- Form of Underwriting Agreement (Filed With SEC on July 30, 2020)
- Form of Letter Agreement among the Registrant, the Sponsor and each director and executive officer of the Registrant (Filed With SEC on July 30, 2020)
- Securities Subscription Agreement, dated April 2, 2020, between the Registrant and the Sponsor (Filed With SEC on July 30, 2020)
- Promissory Note, dated as of April 2, 2020, issued to the Sponsor (Filed With SEC on July 30, 2020)
- Form of Administrative Services Agreement between the Registrant and the Sponsor (Filed With SEC on July 30, 2020)
- Form of Indemnity Agreement (Filed With SEC on July 30, 2020)
- Form of Private Placement Shares Purchase Agreement between the Registrant and the Sponsor (Filed With SEC on July 30, 2020)
- Form of Registration and Shareholder Rights Agreement among the Registrant, the Sponsor and the Holders signatory thereto (Filed With SEC on July 30, 2020)
- Form of Investment Management Trust Agreement between Continental Stock Transfer & Trust Company and the Registrant (Filed With SEC on July 30, 2020)
- Specimen Ordinary Share Certificate (Filed With SEC on July 30, 2020)
